Provectus Pharmaceutical Inc (PVCT) Stock Quote

Detailed Quote for Provectus Pharmaceutical Inc (PVCT)

close 52 Week Information

52 Week High

May 16, 2011

Close: 1.23

52 Week Low

December 23, 2011

Close: 0.67

Today

5d

1m

3m

1y

more

Last Price
0.901

Change $
0.009

Change %
0.99%

Tick
N/A

Bid
0.85

Bid Size
2,500

Ask
0.99

Ask Size
2,500

Open
0.90

High
0.92

Low
0.90

Prev Close
0.91

Last Trade
2/10/12

Volume
92.8 k

52 Wk Hi
1.23

52 Wk Low
0.67

Market Cap
98.79 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
109,640,858

EPS (TTM)
-0.17

PE Ratio
N/A

close Exchange Information Listed On OTC Bulletin Board Consolidated (OTCBB) Exchange
OTCBB

News and Media for Provectus Pharmaceutical Inc (PVCT)

Sector News | Topic News

News for PVCT

Wed, Jan 18, 2012

6:01 AM

Provectus Receives Guidance From FDA On Pathway to Approval for Phase 3 Trial of PV-10 For Metastatic Melanoma - Business Wire

Tue, Jan 17, 2012

4:15 PM

PV-10 Mechanism of Action Data to Be Presented at the Society of Surgical Oncology Annual Meeting March 21-24, 2012 in Orlando, Florida - Business Wire

4:10 PM

Provectus Pharmaceuticals Will Present at the Noble Financial Capital Markets' Eighth Annual Equity Conference on January 18, 2012 - Business Wire

Tue, Dec 20, 2011

7:05 AM

Provectus Pharmaceuticals, Inc. and Its Subsidiaries Complete Unregistered Offering of Units to Facilitate Spin-off of Pure-ific Corporation - Business Wire

Tue, Nov 29, 2011

6:05 AM

Provectus Reports on Third End-of-Phase 2 Meeting with U.S. FDA to Define Pathway to Approval of PV-10 for Metastatic Melanoma - Business Wire

Mon, Nov 14, 2011

11:30 AM

Data on Provectus's PV-10 For Metastatic Melanoma Presented at the 2011 International Melanoma Congress - Business Wire

Fri, Jun 17, 2011

9:00 AM

Market Research on Provectus Pharmaceuticals, Inc. and PolyMedix, Inc. - The Right Prescription - Marketwire

Wed, Jun 17, 2009

5:25 PM

AllPennyStocks.com News: Financial Success That Is More Than Skin-Deep (AVVH.PK, ISA.TO) - Accesswire

More News for PVCT >>

Tags for Provectus Pharmaceutical Inc

Research stocks or mutual funds related to Provectus Pharmaceutical Inc by keywords or tags. Find companies that have a similar focus to PVCT. The keywords below have been associated to PVCT by either user submission or electronic means.

liver cancer cure lung cancer dogs breast cancer metastasis melanoma brain clinical trials database biotech research clinical trial logistics breast cancer foundations biotech stocks clinical research trial breast cancer genes biotech career stage iv breast cancer biotech news employment biotech metastatic liver cancer treatment for breast cancer early signs of skin cancer outsourcing clinical trials biotech jobs breast cancer cells about breast cancer breast cancer causes breast cancer society breast cancer support groups invasive breast cancer breast cancer alternative treatments liver melanoma breast cancer statistic breast cancer survival rate breast cancer staging melanoma mole biotech institutes breast cancer detection phase iii clinical trials radiation treatment for breast cancer prostate cancer breast cancer reconstruction melanoma biopsy pancreatic cancer research clinical research breast cancer support group cancer treatment research breast cancer stages research sec filings biotech fund lung cancer symptoms cancer vaccines breast cancer recovery

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.